Stock Monitor: AAC Holdings Post Earnings Reporting

LONDON, UK / ACCESSWIRE / February 28, 2018 / Active-Investors.com has just released a free earnings report on Phibro Animal Health Corp. (NASDAQ: PAHC) (“Phibro”). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=PAHC. Phibro reported its second quarter fiscal 2018 operating and financial results on February 05, 2018. The maker of animal health products and nutritional supplements outperformed top- and bottom-line expectations. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for AAC Holdings, Inc. (NYSE: AAC), which also belongs to the Healthcare sector as the Company Phibro Animal Health. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=AAC

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Phibro Animal Health most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=PAHC

Earnings Highlights and Summary

Phibro’s net sales of $205.9 million for the three months ended December 31, 2017, increased 7% compared to net sales of $191.6 million in Q2 FY17. The Company’s reported numbers exceeded analysts’ expectations by $11.11 million.

During Q2 FY18, Phibro’s gross profit of $66.9 million, jumped 5% from $63.5 million in Q2 FY17. The Company’s gross profit decreased to 32.5% of net sales for the reported quarter compared to 33.1% for the prior year’s same quarter. Phibro’s Q2 FY18 results included $1.4 million of acquisition-related cost of goods sold.

For Q2 FY18, Phibro’s selling, general, and administrative expenses (SG&A) of $43.0 million, increased 5% from $40.9 million in Q2 FY17. The Company’s SG&A for the reported quarter included $1.7 million in costs relating to the partial settlement of the pension plan. For Q2 FY18, Phibro’s adjusted EBITDA of $32.5 million grew 4% compared to $31.2 million in Q2 FY17.

Phibro’s net income was $7.0 million, or $0.17 per diluted share, for Q2 FY18 compared to net income of $13.4 million, or $0.34 per diluted share, for Q2 FY17. The decrease in earnings was primarily due to a $8.3 million increase in income tax expense.

Phibro’s adjusted earnings were $0.44 per share for Q2 FY18, up 12.8% compared to $0.39 per share in Q2 FY17. Higher gross profit, lower interest expense, net, and a lower effective income tax rate were the primary contributors to the improvement. The Company’s earnings beat Wall Street’s estimates of $0.39 per share.

Phibro Animal Health’s Segment Results

During Q2 FY18, the Animal Health segment’s net sales of $132.8 million advanced 7% compared to $123.7 million in Q2 FY17, primarily due to volume increases across all product groups within the segment. Within the Animal Health division, Nutritional specialty products jumped 12% to $32.6 million on a y-o-y basis, primarily due to volume growth of its products for the dairy and poultry industries in the United States and by penetration into various international countries. The segment’s Vaccines sales rose 7% to $18.2 million, primarily due to volume growth in international markets. The segment’s MFA sales gained 6% to $82.0 million.

Excluding the effects of the acquisition-related cost of goods sold, Animal Health’s gross profit increased $3.9 million on a y-o-y basis due to volume growth, higher average selling prices on selected products, and lower unit costs from improved operating efficiencies. Animal Health’s adjusted EBITDA for the reported quarter edged up 1% to $35.0 million on a y-o-y basis, due to sales growth and increased gross profit.

For Q2 FY18, the Mineral Nutrition segment’s net sales totaled $59.6 million reflecting growth of 5% compared to $56.7 million in Q2 FY17. The increased revenue was due to favorable product mix, plus higher average selling prices resulting from underlying raw material commodity price increases. Mineral Nutrition gross profit increased $0.9 million on a y-o-y basis due to favorable product mix and higher average selling prices. Mineral Nutrition adjusted EBITDA advanced 18% to $5.6 million on a y-o-y basis.

During Q2 FY18, the Performance Products segment’s net sales surged 19% to $13.4 million compared to $11.2 million in Q2 FY17, due to higher average selling prices of copper-based products and higher volumes of copper-based and personal care products. The segment’s adjusted EBITDA was similar to the prior year’s same quarter at $0.3 million as higher volumes and selling prices were offset by higher product costs.

Cash Matters

Phibro had $67 million cash and short-term investments on hand at December 31, 2017. The Company had 2.6x leverage ratio at December 31, 2017, with total debt of $318 million.

Stock Performance Snapshot

February 27, 2018 – At Tuesday’s closing bell, Phibro’s stock was slightly down 0.52%, ending the trading session at $38.55.

Volume traded for the day: 156.06 thousand shares, which was above the 3-month average volume of 106.34 thousand shares.

Stock performance in the last month – up 7.53%; previous three-month period – up 11.26%; past twelve-month period – up 35.74%; and year-to-date – up 15.07%

After yesterday’s close, Phibro’s market cap was at $1.53 billion.

Price to Earnings (P/E) ratio was at 22.58.

The stock has a dividend yield of 1.04%.

The stock is part of the Healthcare sector, categorized under the Specialized Health Services industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 491161

Stock Monitor: Apache Post Earnings Reporting

LONDON, UK / ACCESSWIRE / February 28, 2018 / Active-Investors.com has just released a free earnings report on Pioneer Natural Resources Co. (NYSE: PXD) (“Pioneer”). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=PXD. The Company reported its fourth quarter fiscal 2017 operating and financial results on February 06, 2018. The Shale Oil producer exceeded earnings expectations and announced a fourfold dividend hike. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for Apache Corporation (NYSE: APA), which also belongs to the Basic Materials sector as the Company Pioneer Natural Resources. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=APA

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Pioneer Natural Resources most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=PXD

Earnings Highlights and Summary

For the three months ended December 31, 2017, Pioneer reported revenues of $1.53 billion compared to $1.03 billion in Q4 2016. The Company’s revenue numbers fell short of analysts’ expectations of $1.74 billion.

Pioneer reported a net income attributable to common stockholders of $665 million, or $3.87 per diluted share, in Q4 2017 compared to a net loss of $44 million, or $0.26 loss per diluted share, in Q4 2016. Excluding the effect of non-cash mark-to-market (MTM) derivative losses of $0.99 per diluted share, and a non-cash benefit related to the reduction in Pioneer’s deferred tax liability resulting from the Tax Cuts and Jobs Act 2017 (TCJA) of $3.64 per diluted share, the Company’s adjusted income was $1.22 per diluted share for the reported quarter, beating Wall Street’s estimates of $0.80 per share.

Production Updates

During Q4 2017, Pioneer produced 305 thousand barrels oil equivalent per day (MBOEPD), reflecting an increase of 29 MBOEPD, or 11% on a q-o-q basis. The Company’s reported quarter oil production was up 18 thousand barrels oil per day (MBOPD), or 11%, compared to the prior quarter.

Pioneer’s sales volumes averaged 305 MBOEPD for Q4 2017. The Company’s oil sales averaged 180 thousand barrels per day (MBPD), while NGL sales averaged 62 MBPD and gas sales averaged 377 MMCFPD.

During Q4 2017, Pioneer’s average realized price for oil was $52.81 per barrel. The average realized price for NGLs was $21.64 per barrel, and the average realized price for gas was $2.53 per thousand cubic feet (MCF). The Company’s production costs, including taxes, averaged $7.60 per BOE. Depreciation, depletion, and amortization (DD&A) expenses averaged $13.07 per BOE. Exploration and abandonment costs were $28 million, including $8 million for seismic purchases and $17 million for personnel costs.

Permian Basin Operations

During Q4 2017, Pioneer placed 56 Version 3.0 wells on production in the Permian Basin region. Two of the Version 3.0 wells that were placed on production during the reported quarter were in the Jo Mill interval. The Company plans to drill seven additional Jo Mill appraisal wells during 2018.

Pioneer placed its first Wolfcamp D well with a Version 3.0 completion on production in Midland County during Q4 2017. The well, which had a lateral length of ~9,700 feet, had an initial 24-hour peak production rate of 3.6 MBOEPD and has delivered 45-day cumulative production of 120 MBOE, with an oil content of 72%. This well delivered the strongest 45-day cumulative production for all Pioneer Wolfcamp D wells till the date of the earnings release, and ranked as one of Pioneer’s top producing Wolfcamp wells during its early production days.

For Q4 2017, Pioneer placed 64 horizontal wells on production. Forty-three wells were in the northern area and 21 wells were in the southern Wolfcamp joint venture area.

Pioneer’s Permian Basin horizontal drilling program continues to drive production growth, with total Permian Basin oil production increasing by 14 MBOPD, or 9%, in Q4 2017 compared to Q3 2017.

For 2018, Pioneer is forecasting Permian Basin oil production growth in the range of 19% to 24% on a y-o-y basis. The Company’s total Permian Basin production, on a BOE basis, is also forecasted to grow by 19% to 24% compared to FY17. The Company is expecting internal rates of return (IRRs) averaging 65% for the 2018 drilling program, assuming an oil price of $55.00 per barrel and a gas price of $3.00 per MCF.

Capital Program

For 2018, Pioneer’s capital budget is $2.9 billion, including $2.65 billion for drilling and completion activities, consisting of tank batteries/saltwater disposal facilities and gas processing facilities, and $260 million for water infrastructure, vertical integration, field facilities, and vehicles.

For 2018, the Company’s capital spending is expected to be funded from forecasted operating cash flow of $2.8 billion (assuming average estimated prices of $55.00 per barrel for oil and $3.00 per MCF for gas for 2018), proceeds from asset divestitures, and cash on hand.

Share Repurchase and Dividend

Pioneer announced that its Board of Directors approved a fourfold increase in the Company’s semiannual cash dividend, from $0.04 per share to $0.16 per share on its outstanding common stock. The dividend is payable on April 12, 2018, to stockholders of record at the close of business as on March 29, 2018.

Pioneer’s Board of Directors also approved a common stock repurchase program to offset the impact of dilution associated with annual employee stock awards. The stock repurchase program allows for up to $100 million of common stock to be repurchased during 2018.

Financial Outlook

For the first quarter of FY18, Pioneer is forecasting total production to average between 304 MBOEPD to 314 MBOEPD. The Permian Basin’s production is forecasted to average between 252 MBOEPD to 260 MBOEPD. Pioneer’s production costs are expected to average $7.00 per BOE to $9.00 per BOE.

Stock Performance Snapshot

February 27, 2018 – At Tuesday’s closing bell, Pioneer Natural Resources’ stock declined 2.79%, ending the trading session at $174.67.

Volume traded for the day: 1.68 million shares, which was above the 3-month average volume of 1.60 million shares.

Stock performance in the last three-month – up 13.35%; previous six-month period – up 35.19%; and year-to-date – up 1.05%

After yesterday’s close, Pioneer Natural Resources’ market cap was at $29.69 billion.

Price to Earnings (P/E) ratio was at 147.03.

The stock has a dividend yield of 0.18%.

The stock is part of the Basic Materials sector, categorized under the Independent Oil & Gas industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 491162

NEW YORK, NY / ACCESSWIRE / February 28, 2018 / CIRCOR International, Inc. (NYSE: CIR) will be discussing their earnings results in their Q4 Earnings Call to be held on February 28, 2018, at 9:00 AM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/3029.

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 490885

NEW YORK, NY / ACCESSWIRE / February 28, 2018 / Enel Chile SA (NYSE: ENIC) will be discussing their earnings results in their Q4 Earnings Call to be held on February 28, 2018, at 9:00 AM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/40327.

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 490886

NEW YORK, NY / ACCESSWIRE / February 28, 2018 / EOG Resources, Inc. (NYSE: EOG) will be discussing their earnings results in their Q4 Earnings Call to be held on February 28, 2018, at 9:00 AM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/3337.

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 490887

Stock Monitor: Universal Electronics Post Earnings Reporting

LONDON, UK / ACCESSWIRE / February 28, 2018 / Active-Investors.com has just released a free earnings report on Fabrinet (NYSE: FN). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=FN. Fabrinet reported its second quarter fiscal 2018 operating and financial results on February 05, 2018. The Company that assembles optical, electro-mechanical and electronic devices provided guidance for the upcoming quarter. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for Universal Electronics Inc. (NASDAQ: UEIC), which also belongs to the Consumer Goods sector as the Company Fabrinet. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=UEIC

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Fabrinet most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=FN

Earnings Highlights and Summary

Fabrinet’s revenue for the second quarter of the fiscal year 2018 was $337.1 million compared to revenue of $351.2 million for Q2 FY17. The Company’s reported numbers exceeded analysts’ estimates of $330.2 million.

During Q2 FY18, Fabrinet’s GAAP net income was $19.3 million, or $0.51 per diluted share, compared to GAAP net income of $25.3 million, or $0.67 per diluted share, for Q2 FY17. The Company’s reported quarter results included a foreign exchange loss of $0.04 per diluted share, compared to a foreign exchange gain of $0.05 per diluted share for the year-ago same period.

Fabrinet’s non-GAAP net income was $27.3 million, or $0.72 per diluted share, for Q2 FY18 compared to non-GAAP net income of $34.5 million, or $0.91 per diluted share, in Q2 FY17. The Company’s reported quarter results included a foreign exchange loss of $0.04 per diluted share.

Segment Results

During Q2 FY18, Fabrinet’s Optical communications numbers represented 72% of total revenue compared to 77% in Q1 FY18 and non-optical increased to 28% of total revenue.

Within optical revenue, 100 Gig solutions were $133 million in Q2 FY18 compared to $157 million in Q1 FY17. The segment’s revenue from QSFP28 transceivers was $42 million in the reported quarter compared to $48 million in the prior quarter, as the numbers of customers continued to transition to a low-cost CWDM4 variant. Silicon photonic revenue was $74 million in Q2 FY18, down slightly from $77 million in Q1 FY18.

The Company’s non-optical communication segment generated record revenues of $95.2 million in Q2 FY18, while revenue from industry laser was a record $43 million, up 15% q-o-q and 20% on a y-o-y basis. Automotive revenue was also a quarterly record at nearly $26 million, increased 20% from the previous quarter and 18% from the year-ago same period.

In Q2 FY18, Fabrinet’s new business revenue was $119 million consistent with Q1 FY18, and it represented 35% of total revenue.

Cash Matters

At the end of Q2 FY18, Fabrinet’s cash and investments were $287.7 million. This represents an increase of approximately $21 million from the end of Q1 FY17, primarily from the operating cash flows of $40.2 million, offset by a capital expenditure of $10.2 million, and share repurchase of $10 million.

Share Repurchase Program

Fabrinet announced that its Board of Directors has approved the repurchase of up to an additional $30.0 million of Fabrinet’s ordinary shares, bringing the aggregate authorization under the Company’s existing share repurchase program to $60.0 million. Fabrinet repurchased approximately 316,000 shares of its ordinary shares at an average price of $31.36 during Q2 FY18.

Business Outlook

For its third fiscal quarter ending March 30, 2018, Fabrinet is forecasting revenue to be in the range of $316 million to $324 million. The Company is expecting GAAP net income per diluted share to be in the range of $0.50 to $0.53, and non-GAAP net income per diluted share to be in the band of $0.70 to $0.73 per share.

Stock Performance Snapshot

February 27, 2018 – At Tuesday’s closing bell, Fabrinet’s stock climbed 1.18%, ending the trading session at $30.07.

Volume traded for the day: 600.96 thousand shares.

Stock performance in the last month – up 15.97%; and year-to-date – up 4.77%

After yesterday’s close, Fabrinet’s market cap was at $1.13 billion.

Price to Earnings (P/E) ratio was at 12.81.

The stock is part of the Consumer Goods sector, categorized under the Electronic Equipment industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 491142

LONDON, UK / ACCESSWIRE / February 28, 2018 / Active-Investors.com has just released a free earnings report on General Motors Co. (NYSE: GM). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=GM. The Company posted its financial results on February 06, 2018, for the fourth quarter of the fiscal year 2017 (Q4 FY17) and for the full fiscal year 2017 (FY17). The Detroit, Michigan-based Company’s quarterly adjusted diluted earnings per share (EPS) grew 21.3% y-o-y, beating market consensus estimates. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, General Motors most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=GM

Earnings Highlights and Summary

In Q4 FY17, General Motors reported total net sales and revenues of $37.72 billion compared to $39.90 billion in Q4 FY16. The Company’s total revenue numbers for the reported quarter outperformed market expectations of $33.3 billion.

The automobile Company reported a GAAP net loss attributable to stockholders of $5.17 billion, or $3.65 loss per diluted share, in Q4 FY17 compared to a GAAP net income attributable to stockholders of $1.84 billion, or $1.19 per diluted share, in Q4 FY16. The Company’s adjusted net income stood at $2.38 billion, or $1.65 per diluted share, for the reported quarter, increasing from $2.10 billion, or $1.36 per diluted share, in Q4 FY16. Wall Street had expected the Company to report a diluted adjusted EPS of $1.34.

For FY17, General Motors’ revenues were $145.59 billion, which came in 2.4% lower than $149.18 billion in FY16. The Company reported a GAAP net loss attributable to stockholders of $3.88 billion, or $2.60 loss per diluted share, in FY17 compared to a GAAP net income attributable to stockholders of $9.43 billion, or $6.00 per diluted share, in FY16. Additionally, the Company’s adjusted net income stood at $9.88 billion, or $6.62 per diluted share, for FY17 compared to $9.61 billion, or $6.12 per diluted share, in FY16.

Operating Metrics

During Q4 FY17, General Motors’ total operating segment profits stood at $3.59 billion compared to $3.07 billion in the previous year’s same period. The Company’s adjusted earnings before interest and taxes (EBIT) came in at $3.09 billion in Q4 FY17 versus $2.60 billion Q4 FY16. Furthermore, the Company’s retail sales totaled 2.59 million vehicles around the globe in Q4 FY17, up from 2.85 million vehicles in Q4 FY16.

Segment Performance

General Motors’ North America segment’s revenues fell to $28.75 billion during Q4 FY17 from $31.30 billion in the prior year’s comparable quarter. The segment’s profit increased to $2.88 billion in Q4 FY17 from $2.68 billion in Q4 FY16.

In the reported period, General Motors’ International segment’s revenues fell to $5.69 billion from $6.01 billion in Q4 FY16. The segment reported an operating profit of $416 million in Q4 FY17, higher than the $223 million recorded in the year-ago corresponding quarter.

General Motors’ Financial segment’s revenues surged to $3.25 billion during Q4 FY17 from $2.55 billion in Q4 FY16. The segment’s profit stood at $301 million for the reported quarter, which came in above the $163 million recorded in the year-ago same quarter.

Cash Flow and Balance Sheet

During the year ended December 31, 2017, General Motors generated $17.33 billion in cash from operations versus $16.61 billion at the end of the previous year. In the reported financial year, the Company’s adjusted automotive free cash flow was $4.47 billion versus $6.93 billion in FY16. The Company had cash and cash equivalents of $15.51 billion as on December 31, 2017, compared to $12.57 billion at the close of books on December 31, 2016. Furthermore, the Company had automotive long-term debt and financial long-term debt amounting to $10.99 billion and $56.27 billion, respectively, as on December 31, 2017.

Dividend and Share Repurchases

On February 05, 2018, General Motors’ Board of Directors declared a quarterly dividend of $0.38 per share, payable on March 23, 2018, to shareholders of record at the close of business on March 09, 2018.

During FY17, the Company returned $6.7 billion to its shareholders through share buybacks of $4.5 billion and dividends of $2.2 billion.

Stock Performance Snapshot

February 27, 2018 – At Tuesday’s closing bell, General Motors’ stock dropped 3.30%, ending the trading session at $40.17.

Volume traded for the day: 12.65 million shares.

Stock performance in the previous six-month period – up 12.84%; and past twelve-month period – up 7.78%

After yesterday’s close, General Motors’ market cap was at $57.06 billion.

Price to Earnings (P/E) ratio was at 7.81.

The stock has a dividend yield of 3.78%.

The stock is part of the Consumer Goods sector, categorized under the Auto Manufacturers-Major industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 491146

Stock Monitor: Great Panther Silver Post Earnings Reporting

LONDON, UK / ACCESSWIRE / February 28, 2018 / Active-Investors.com has just released a free research report on Hecla Mining Co. (NYSE: HL). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=HL as the Company’s latest news hit the wire. On February 26, 2018, the Company disclosed that it has entered into a toll milling agreement (TMA) with Excellon Resources Inc. As per the agreement the sulphide ore from Hecla’s San Sebastian mine would be transported to Excellon’s Miguel Auza flotation mill facility for processing. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for Great Panther Silver Limited (NYSE AMERICAN: GPL), which also belongs to the Basic Materials sector as the Company Hecla Mining. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=GPL

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Hecla Mining most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=HL

The agreement will not only allow Hecla to increase its metal production from the San Sebastian mine but also extend the mine’s life. The financial details of the deal were not disclosed by any of the companies.

Comments from Management

Commenting on the TMA, Phillips S. Baker, Jr., Hecla’s President and CEO, said:

“This is a significant step towards extending the life of the San Sebastian mine and is in keeping with our strategy of maximizing the cash flow and minimizing capital investment by using third-party facilities.”

Brendan Cahill, President, and CEO of Excellon, added:

“This arrangement provides opportunities for additional operating cash flow to the Company and lower milling cost per tonne and all-in sustaining cost from Platosa. Our Milling Facility’s exceptional scalability has made this opportunity possible, with ample capacity remaining to process increased Platosa production and potential new discoveries at either Platosa or Miguel Auza.”

Details of the TMA

As per the terms of the TMA sulphide ore from Hecla’s San Sebastian mine would be transported 26 miles for processing at Excellon’s Miguel Auza flotation mill facility, in Zacatecas, Mexico. Excellon will provide Hecla with processing 440 tons per day of milling capacity or approximately 12,000 tons per month. The duration of the TMA is 5 years with a provision for an extension for an additional two years.

The agreement is dependent on the Excellon’s capability of successfully processing a 4,400-ton bulk sample of sulphide ore from Hecla’s polymetallic Hugh Zone in Q3 2018. The deal is subject to completion of due diligence, receipt of regulatory approvals and third-party consents. The TMA is expected to begin in 2019. At the start of the TMA and after completing the bulk sample processing, the Miguel Auza Facility will produce a copper-lead concentrate and a zinc concentrate from San Sebastian ore. Once the TMA is implemented, Excellon plans to upgrade this facility and install a copper flotation circuit to produce copper, lead, and zinc concentrates.

For Excellon, the TMA will allow it to reduce the cost of milling per ton, increase its cash flows and reduce the all-in sustaining cost (AISC) payable per ounce on production at its Platosa Mine. Even after setting aside processing capacity for Hecla, Excellon will have enough processing capacity to process any increased output from its Platosa Mine or from potential new discoveries at either Platosa or Miguel Auza.

At present Excellon’s Miguel Auza facility has a milling capacity of 800 tons per day, crushing capacity of over 1,000 tons per day. Excellon does not require the milling capacity or crushing capacity for the ore from its Platosa mine as they are crushed on site. Excellon is in discussions with Hecla for reviewing current flotation capacity, however, it is confident that the current processing capacity at the facility would easily accommodate Hecla’s processing needs under the TMA as well as the bulk sample. Excellon is also in talks with Hecla for an upgrading of the facility to install the copper flotation circuit.

About Excellon Resources Inc.

Toronto, Canada-based Excellon owns 100% of the Platosa Mine in Durango, Mexico. The Platosa Mine is Mexico’s highest-grade silver mine and began production in 2005. The Company is focused on optimizing the Platosa Mine’s cost and production profile, discovering further high-grade silver and carbonate replacement deposit (CRD) mineralization on the Platosa Project and epithermal silver mineralization on the Miguel Auza Property and capitalizing on the opportunity in current market conditions to acquire undervalued projects in the Americas.

About Hecla Mining Co.

Coeur d’Alene, Idaho-based Hecla was founded in 1891 and is a leading low-cost silver producer in US with operating mines in Alaska (Greens Creek), Idaho (Lucky Friday), and Mexico (San Sebastian). The Company is also a growing gold producer with an operating mine in (Casa Berardi) Quebec, Canada. Hecla has several exploration properties and pre-development projects in seven world-class silver and gold mining districts in North America. With an active exploration and development program, the Company has consistently grown its reserve base for future production, with 2017 reserves totaling 172 million ounces of silver and 2 million ounces of gold reserves.

Stock Performance Snapshot

February 27, 2018 – At Tuesday’s closing bell, Hecla Mining’s stock declined 2.60%, ending the trading session at $3.75.

Volume traded for the day: 2.74 million shares.

After yesterday’s close, Hecla Mining’s market cap was at $1.50 billion.

The stock has a dividend yield of 0.27%.

The stock is part of the Basic Materials sector, categorized under the Silver industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 491148

Stock Monitor: Blueprint Medicines Post Earnings Reporting

LONDON, UK / ACCESSWIRE / February 28, 2018 / Active-Investors.com has just released a free research report on ObsEva S.A. (NASDAQ: OBSV). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=OBSV as the Company’s latest news hit the wire. On February 26, 2018, the clinical-stage biopharmaceutical Company announced that it has released positive top-line results of the IMPLANT2 Phase-3 clinical trial evaluating nolasiban, which is being developed for improving pregnancy rate following in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) procedures. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for Blueprint Medicines Corporation (NASDAQ: BPMC), which also belongs to the Healthcare sector as the Company ObsEva. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=BPMC

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, ObsEva most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=OBSV

Follow-up data from the IMPLANT2 study will include live birth rate, and 28-day neonatal safety, expected to be reported in the fourth quarter of 2018.

IMPLANT2 Clinical Trial

IMPLANT2 is a randomized, double blind, placebo controlled clinical trial assessing nolasiban compared to placebo for improving the rate of pregnancy in patients undergoing IVF or ICSI due to low fertility. The study enrolled 778 patients from 41 fertility clinics across nine European countries. Following ovarian stimulation, egg retrieval and fertilization, prospective patients received either a single 900 mg dose of nolasiban or placebo orally on the day of embryo transfer (ET). Recruitment included patients undergoing single, fresh ET on day 3 or on day 5 after oocyte retrieval. The primary endpoint of the trial was ongoing pregnancy as determined by ultrasound at 10 weeks following ET.

Primary Endpoint of the Clinical Trial was Met

These top-line results included efficacy and safety data up to week 10 of pregnancy following embryo transfer. The primary endpoint of the clinical trial was met, with an absolute increase in ongoing pregnancy rate at 10 weeks of 7.1%, representing a relative increase of 25% in the ongoing pregnancy rate after administration of nolasiban compared to placebo. In the ET D5 subgroup, the absolute increase was 11.2% in favor of nolasiban, representing a relative increase in ongoing pregnancy rate of 32% after administration of nolasiban compared to placebo. In the ET D3 subgroup, there was a statistically non-significant 3.1% absolute increase in favor of nolasiban, or a 14% relative increase in ongoing pregnancy rate after administration of nolasiban compared to placebo. Nolasiban was well tolerated, with low rates of treatment discontinuation, and its safety profile was similar to placebo’s. No serious adverse events were reported.

Results Represent a Highly Clinically Meaningful Improvement for the Women Undergoing IVF/ICSI Procedures

Ernest Loumaye, MD, PhD, OB/GYN, CEO and Co-Founder of ObsEva, stated that the Company is pleased that the IMPLANT2 results demonstrate an ongoing pregnancy benefit at 10 weeks following a single, oral dose of nolasiban, given 4 hours prior to a single ET, that not only was statistically significant, but the magnitude of which will represent a highly clinically meaningful improvement for the women undergoing IVF/ICSI procedures. Ernest added that IMPLANT2 results potentially represent one of the most important innovations in the practice of IVF/ICSI since the emergence of recombinant FSH more than 20 years ago.

About Nolasiban

Nolasiban is an oral oxytocin receptor antagonist with the potential to decrease contractions, improve uterine blood flow and enhance the receptivity of the endometrium to embryo implantation. This may increase the chance of successful implantation and live-birth rates among patients undergoing ART. ObsEva licensed nolasiban from Merck-Serono in 2013 and retains worldwide, exclusive, commercial rights.

About Assisted Reproductive Technology

Assisted reproductive technology (ART) is the technology used to achieve pregnancy in procedures such as fertility medication, in vitro fertilization, and surrogacy. It is reproductive technology used primarily for infertility treatments. It mainly belongs to the field of reproductive endocrinology and infertility and may also include intracytoplasmic sperm injection (ICSI) and cryopreservation. Some forms of ART are also used with regard to fertile couples for genetic reasons. While the success of ART depends on multiple factors such as embryo quality and ET procedure, a successful pregnancy ultimately hinges on the receptivity of the uterus to accept embryo implantation.

About ObsEva S.A.

Founded in 2012 and headquartered in Switzerland, ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy.

Stock Performance Snapshot

February 27, 2018 – At Tuesday’s closing bell, ObsEva’s stock was slightly up 0.76%, ending the trading session at $14.61.

Volume traded for the day: 49.61 thousand shares, which was above the 3-month average volume of 35.63 thousand shares.

Stock performance in the last month – up 35.28%; previous three-month period – up 46.25%; past twelve-month period – up 4.43%; and year-to-date – up 49.69%

After yesterday’s close, ObsEva’s market cap was at $509.74 million.

The stock is part of the Healthcare sector, categorized under the Biotechnology industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 491158

NEW YORK, NY / ACCESSWIRE / February 28, 2018 / HEICO Corporation (NYSE: HEI) will be discussing their earnings results in their Q1 Earnings Call to be held on February 28, 2018, at 9:00 AM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/1760.

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 490882